Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MLEC
Upturn stock ratingUpturn stock rating

Moolec Science SA Ordinary Shares (MLEC)

Upturn stock ratingUpturn stock rating
$6.3
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: MLEC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $3

1 Year Target Price $3

Analysts Price Target For last 52 week
$3Target price
Low$5.3
Current$6.3
high$11

Analysis of Past Performance

Type Stock
Historic Profit -27.53%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 28.40M USD
Price to earnings Ratio -
1Y Target Price 3
Price to earnings Ratio -
1Y Target Price 3
Volume (30-day avg) 1
Beta -0.32
52 Weeks Range 5.30 - 11.00
Updated Date 06/29/2025
52 Weeks Range 5.30 - 11.00
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.1

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -21.69%
Return on Equity (TTM) -174.68%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 48558480
Price to Sales(TTM) 3.48
Enterprise Value 48558480
Price to Sales(TTM) 3.48
Enterprise Value to Revenue 6.2
Enterprise Value to EBITDA -1.01
Shares Outstanding 4000370
Shares Floating 897815
Shares Outstanding 4000370
Shares Floating 897815
Percent Insiders 27.12
Percent Institutions 0.13

Analyst Ratings

Rating 1
Target Price 3
Buy 1
Strong Buy -
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Moolec Science SA Ordinary Shares

stock logo

Company Overview

overview logo History and Background

Moolec Science SA is a food-tech company focused on producing animal proteins in plants using molecular farming. Founded in 2020, it aims to create sustainable and affordable alternatives to animal products.

business area logo Core Business Areas

  • Molecular Farming: Developing and producing animal proteins within plants to create ingredients for the food industry.
  • Hybrid Plant-Based Foods: Utilizing molecular farming to enhance the taste, texture, and nutritional profile of plant-based foods.

leadership logo Leadership and Structure

The leadership team consists of Gastu00f3n Paladini (CEO), based out of Europe and a Board of Directors that guides the company's strategy.

Top Products and Market Share

overview logo Key Offerings

  • SPC (Soy Protein Concentrate) with Bovine Myoglobin: Moolec's lead product, Piggy Sooy, aims to improve the taste and texture of plant-based meat alternatives by incorporating bovine myoglobin into soybeans. Market share is still emerging. Competitors include Impossible Foods, Beyond Meat.
  • Gamma Linolenic Acid (GLA) from Safflower: GLA safflower oil can be used in supplements and food products. Market share is still emerging. Competitors are manufacturers of GLA supplements and oils.

Market Dynamics

industry overview logo Industry Overview

The plant-based and cultivated meat industries are experiencing significant growth, driven by increasing consumer demand for sustainable and ethical food options. However, taste and cost remain key challenges.

Positioning

Moolec aims to differentiate itself by using molecular farming to produce animal proteins in plants, potentially offering a cost-effective and scalable solution compared to traditional animal agriculture and cell-based meat production.

Total Addressable Market (TAM)

The TAM for plant-based meat alternatives and cultivated meat is estimated to reach billions of dollars in the coming years. Moolec is positioned to capture a share of this market by addressing the taste and cost challenges of existing plant-based products.

Upturn SWOT Analysis

Strengths

  • Innovative technology (molecular farming)
  • Potential for cost-effective production
  • Sustainable approach
  • Focus on improving taste and texture of plant-based foods

Weaknesses

  • Early stage company
  • Limited commercial production
  • Regulatory hurdles for genetically modified crops
  • Public perception of genetically modified foods

Opportunities

  • Growing demand for plant-based and cultivated meat
  • Partnerships with food companies
  • Expansion into new markets
  • Technological advancements in molecular farming

Threats

  • Competition from established players in the plant-based and cultivated meat industries
  • Changing consumer preferences
  • Regulatory changes
  • Scientific uncertainty and technological challenges

Competitors and Market Share

competitor logo Key Competitors

  • BYND
  • IMPOSSIBLE FOODS (PRIVATE)
  • TATTL (PRIVATE)

Competitive Landscape

Moolec is a small player compared to established plant-based meat companies and is very innovative compared to the larger competitors. It is focused on specific ingredient markets.

Growth Trajectory and Initiatives

Historical Growth: Limited historical data.

Future Projections: Future growth depends on the successful commercialization of Piggy Sooy and other products. Analyst estimates vary.

Recent Initiatives: Focus on scaling up production and securing regulatory approvals.

Summary

Moolec Science SA is an early-stage company with an innovative approach to producing animal proteins in plants. While it faces significant challenges, including regulatory hurdles and competition from established players, the growing demand for sustainable and affordable food options presents a significant opportunity. The company's success hinges on the successful commercialization of its products and the scalability of its molecular farming technology. Moolec needs to focus on securing regulatory approvals, scaling up production, and building strategic partnerships to gain market share. MOLE is highly volatile and high risk, but potentially very high reward.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company website
  • Press releases
  • Industry reports

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. The information provided is based on publicly available data and analyst estimates, which are subject to change. Investing in early-stage companies involves significant risks.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Moolec Science SA Ordinary Shares

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-01-03
CEO -
Sector Healthcare
Industry Biotechnology
Full time employees -
Full time employees -

Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.